Cytokeratin-positive follicular dendritic cell sarcoma: A mimic of carcinoma [0.03%]
CK阳性滤泡型树突细胞肿瘤：一种类似癌的疾病状态
Elizabeth Ricks,Shimin Hu,Zhihong Hu
Elizabeth Ricks
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome [0.03%]
慢性淋巴细胞性白血病的第二原发恶性肿瘤：皮肤、实体器官、血液系统及里特综合症
Yandong Shen,Luke Coyle,Ian Kerridge et al.
Yandong Shen et al.
Chronic lymphocytic leukaemia (CLL) is invariably accompanied by some degree of immune failure, and CLL patients have a high rate of second primary malignancy (SPM) compared to the general population. We comprehensively documented the incid...
Richter transformation with marked plasmacytic differentiation, mimicking plasma cell neoplasm [0.03%]
里奇尔转化伴显著浆细胞分化，类似浆细胞增殖性疾病
Shaoying Li,Jie Xu,C Cameron Yin et al.
Shaoying Li et al.
Primary cutaneous diffuse large B-cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression [0.03%]
以MYC/BCL2/BCL6过表达为特征的好发于腿部的原发性皮肤弥漫性大B细胞淋巴瘤
Yosuke Okada,Takehiro Sone,Kohei Takada et al.
Yosuke Okada et al.
Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma [0.03%]
CARTITUDE-1中西妥昔珠单抗自体T细胞治疗与Flatiron Health多发性骨髓瘤队列登记中的医师选择治疗方案在复发或难治性多发性骨髓瘤患者中的疗效比较
Thomas Martin,Amrita Krishnan,Kwee Yong et al.
Thomas Martin et al.
Introduction: Ciltacabtagene autoleucel (cilta-cel) is a novel chimeric antigen receptor T-cell therapy that is being evaluated in the CARTITUDE-1 trial (NCT03548207) in patients with relapsed or refractory multiple myelo...
Donor-derived lymphoma harboring a mosaic sex chromosome in a female stem cell transplantation recipient from a male sibling [0.03%]
来自男性同胞的女性干细胞移植受者中出现携带嵌合性别的供体衍生淋巴瘤
Osamu Imataki,Hiroyuki Kubo,Jun-Ichiro Kida et al.
Osamu Imataki et al.
Case Reports
EJHaem. 2021 Dec 2;3(1):228-230. DOI:10.1002/jha2.347 2021
Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia [0.03%]
血小板减少症患者输注冷沉淀代替血小板的疗效
Philip Crispin,Sarah Hicks,Lucy A Coupland et al.
Philip Crispin et al.
Platelet transfusions are not always available for bleeding in severe thrombocytopenia, as storage outside of major centers is limited by their short shelf-life. Data are lacking to support alternative available blood products; however, add...
Lymphoid blast crisis after prolonged treatment-free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de-escalation during the COVID-19 pandemic [0.03%]
新冠大流行期间酪氨酸激酶抑制剂减药期间慢性粒细胞白血病患者获得长期无治疗缓解后发生淋巴母细胞危象
Daniele Avenoso,Dragana Milojkovic,James Clark et al.
Daniele Avenoso et al.
During the COVID-19 pandemic, access to health services has been considerably restricted and furthermore, patients have been reluctant to attend for routine monitoring, and this may have had a negative impact in the management of patients a...
Case Reports
EJHaem. 2021 Nov 19;3(1):215-217. DOI:10.1002/jha2.302 2021
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group [0.03%]
达雷妥尤单抗联合地塞米松和来那度胺或硼替佐米治疗复发/难治性多发性骨髓瘤患者的疗效：意大利GIMEMA拉齐奥组的报告
Francesca Fazio,Luca Franceschini,Valeria Tomarchio et al.
Francesca Fazio et al.
The multiple myeloma (MM) treatment has changed over the last years due to the introduction of novel drugs. Despite improvements in the MM outcome, MM remains an incurable disease. Daratumumab is a human IgGK monoclonal antibody targeting C...
Christian Berthou,Jean Paul Iliou,Denis Barba
Christian Berthou
Medical management of iron deficiency (ID) requires to consider its consequences in biochemical and physiological plural functions, beyond heme/hemoglobin disrupted synthesis. Fatigue, muscle weakness, reduced exercise capacity, changes in ...